Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Gyros completes record financing round:

This article was originally published in Clinica

Executive Summary

Swedish microfluidic technologies company Gyros (Stockholm) has completed what it says is the largest single round of biotech venture funding the country has seen. New investors, led by 3i, have backed the company to the tune of SKr309 million ($30 million) in the round which finished this month. Other new shareholders include the Swedish Industrial Development Fund, InnovationsKapital and H&B Capital. Last year, in the first round, Gyros raised SKr285 million. The microfluidic/microchip market for life sciences is expected to reach $1.2 billion by 2004, say analysts. Gyros, with a proteomics segment product launch slated for 2002, is poised to benefit from the market upsurge.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts